LEVOCETIRIZINE DIHYDROCHLORIDE

LEVOCETIRIZINE DIHYDROCHLORIDE was reported 24411 times

LEVOCETIRIZINE DIHYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMAUROSIS FUGAX 226 0.2098
1 URINARY TRACT DISORDER 194 0.0430
2 HAEMORRHAGIC STROKE 305 0.0390
3 TRISOMY 18 12 0.0315
4 OCULAR DISCOMFORT 246 0.0219
5 MAST CELL ACTIVATION SYNDROME 29 0.0207
6 INFUSION SITE DISCHARGE 32 0.0182
7 GENERALISED OEDEMA 216 0.0174
8 FEBRILE CONVULSION 20 0.0164
9 HEAD DISCOMFORT 270 0.0152
10 NASAL PRURITUS 19 0.0152
11 ALTERED STATE OF CONSCIOUSNESS 321 0.0148
12 ALOPECIA AREATA 25 0.0142
13 INFUSION SITE RASH 19 0.0138
14 INFUSION SITE MASS 15 0.0138
15 INFUSION SITE PRURITUS 43 0.0136
16 INFUSION SITE BRUISING 29 0.0134
17 HANGOVER 47 0.0134
18 CONJUNCTIVITIS ALLERGIC 19 0.0128
19 INFUSION SITE SWELLING 78 0.0124
20 OBSTRUCTIVE SLEEP APNOEA SYNDROME 18 0.0123
21 FOETAL MALFORMATION 13 0.0120
22 SEASONAL ALLERGY 158 0.0112
23 NAIL GROWTH ABNORMAL 12 0.0109
24 SOMNOLENCE 2163 0.0107
25 INFUSION SITE INDURATION 15 0.0101
26 UPPER RESPIRATORY TRACT INFLAMMATION 12 0.0100
27 INFUSION SITE WARMTH 12 0.0098
28 PHOTOPHOBIA 184 0.0098
29 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 13 0.0096
30 PRESYNCOPE 230 0.0095
31 INFUSION SITE ERYTHEMA 79 0.0094
32 HAEMATEMESIS 237 0.0093
33 RHINITIS ALLERGIC 41 0.0092
34 MULTIPLE ALLERGIES 72 0.0092
35 INFUSION SITE HAEMORRHAGE 30 0.0091
36 SNEEZING 202 0.0090
37 UPPER-AIRWAY COUGH SYNDROME 72 0.0087
38 SINUS PAIN 20 0.0086
39 PHARYNGEAL SWELLING 83 0.0085
40 NOROVIRUS INFECTION 12 0.0083
41 ASCITES 239 0.0081
42 DIPLOPIA 208 0.0080
43 NASAL DRYNESS 50 0.0080
44 PARANASAL SINUS DISCOMFORT 30 0.0079
45 INFUSION SITE PAIN 102 0.0079
46 NASAL OEDEMA 14 0.0077
47 HEREDITARY ANGIOEDEMA 83 0.0077
48 ACUTE SINUSITIS 13 0.0075
49 PRE-EXISTING CONDITION IMPROVED 46 0.0074
50 NASAL POLYPS 36 0.0073
51 DRUG EFFECT LESS THAN EXPECTED 107 0.0072
52 SLEEP DEFICIT 15 0.0071
53 SKIN WEEPING 25 0.0070
54 THERAPEUTIC RESPONSE DELAYED 19 0.0068
55 CARDIO-RESPIRATORY ARREST 281 0.0067
56 INFUSION SITE REACTION 20 0.0067
57 CYTOLYTIC HEPATITIS 22 0.0066
58 THERAPEUTIC RESPONSE DECREASED 395 0.0065
59 ENTERITIS INFECTIOUS 11 0.0065
60 DEVICE INFUSION ISSUE 16 0.0064
61 MOTION SICKNESS 12 0.0062
62 DERMATITIS CONTACT 71 0.0062
63 HAEMATURIA 213 0.0062
64 INSURANCE ISSUE 94 0.0061
65 BLINDNESS 247 0.0061
66 EYE PAIN 341 0.0060
67 ALLERGIC REACTION TO EXCIPIENT 12 0.0060
68 THERAPEUTIC PRODUCT EFFECT DELAYED 27 0.0059
69 EYELID PAIN 12 0.0059
70 MIDDLE EAR EFFUSION 13 0.0059
71 SINUS OPERATION 14 0.0059
72 THERAPEUTIC RESPONSE SHORTENED 186 0.0056
73 CHRONIC SINUSITIS 21 0.0056
74 INFUSION SITE INFECTION 13 0.0056
75 TINNITUS 257 0.0056
76 EYE PRURITUS 187 0.0056
77 SINUS DISORDER 108 0.0054
78 SINUSITIS 557 0.0054
79 EAR INFECTION 141 0.0053
80 PRODUCT ADMINISTRATION INTERRUPTED 41 0.0052
81 RHINORRHOEA 331 0.0051
82 RHINITIS 41 0.0051
83 COMA 241 0.0051
84 URINARY HESITATION 12 0.0050
85 HYPERURICAEMIA 20 0.0049
86 LACRIMATION INCREASED 147 0.0049
87 DERMATITIS ATOPIC 256 0.0049
88 MOUTH SWELLING 28 0.0048
89 DRY THROAT 49 0.0048
90 NASAL CONGESTION 278 0.0047
91 SOMNAMBULISM 31 0.0047
92 SINUS HEADACHE 28 0.0047
93 INCORRECT DRUG ADMINISTRATION RATE 20 0.0047
94 SKIN FISSURES 91 0.0047
95 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 79 0.0046
96 IMPAIRED QUALITY OF LIFE 66 0.0046
97 OTITIS MEDIA 15 0.0045
98 SINUS CONGESTION 61 0.0045
99 SNORING 17 0.0045
100 SKIN ABRASION 21 0.0044
101 HYPERSOMNIA 126 0.0044
102 HORDEOLUM 19 0.0044
103 EAR DISORDER 20 0.0044
104 EOSINOPHILIC OESOPHAGITIS 12 0.0043
105 UPPER RESPIRATORY TRACT INFECTION 200 0.0043
106 ERYTHEMA MULTIFORME 40 0.0043
107 EAR PRURITUS 15 0.0043
108 FOOD ALLERGY 33 0.0043
109 ASTHMA 483 0.0043
110 GASTROENTERITIS VIRAL 74 0.0041
111 SCRATCH 43 0.0041
112 PHARYNGITIS 50 0.0040
113 INFUSION SITE EXTRAVASATION 25 0.0040
114 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13 0.0040
115 SPINAL OSTEOARTHRITIS 35 0.0040
116 DRUG TOLERANCE 20 0.0039
117 GLOSSITIS 14 0.0039
118 DRUG TOLERANCE DECREASED 11 0.0039
119 PERIORBITAL SWELLING 22 0.0039
120 PHARYNGITIS STREPTOCOCCAL 42 0.0039
121 THERAPEUTIC PRODUCT EFFECT VARIABLE 15 0.0039
122 SPONDYLITIS 14 0.0038
123 LIGAMENT SPRAIN 38 0.0038
124 SLEEP APNOEA SYNDROME 73 0.0038
125 NASAL DISCOMFORT 30 0.0038
126 OBSTRUCTION 15 0.0038
127 ENURESIS 15 0.0037
128 AUTOIMMUNE THYROIDITIS 14 0.0037
129 TACHYCARDIA 328 0.0037
130 DRY EYE 184 0.0037
131 RESPIRATORY TRACT INFECTION 96 0.0037
132 ATYPICAL PNEUMONIA 11 0.0037
133 PARANASAL SINUS HYPERSECRETION 14 0.0037
134 BRONCHITIS 269 0.0036
135 LYME DISEASE 12 0.0036
136 RHINOVIRUS INFECTION 14 0.0036
137 ECZEMA 186 0.0036
138 URTICARIA 594 0.0035
139 PRURITUS 1357 0.0035
140 SLUGGISHNESS 36 0.0035
141 NIGHTMARE 122 0.0035
142 BRAIN FOG 55 0.0035
143 DRUG ERUPTION 62 0.0035
144 ABNORMAL DREAMS 96 0.0035
145 FUNCTIONAL GASTROINTESTINAL DISORDER 12 0.0035
146 SPINAL FUSION SURGERY 14 0.0034
147 PERIPHERAL VENOUS DISEASE 14 0.0034
148 HAEMORRHAGE SUBCUTANEOUS 12 0.0034
149 CHILLS 395 0.0034
150 RESPIRATORY TRACT CONGESTION 53 0.0033
151 ANAPHYLACTIC REACTION 184 0.0033
152 LYMPHOEDEMA 23 0.0033
153 FACE OEDEMA 56 0.0033
154 EAR DISCOMFORT 34 0.0033
155 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 18 0.0033
156 SKIN HAEMORRHAGE 49 0.0033
157 THROAT IRRITATION 148 0.0033
158 CUTANEOUS VASCULITIS 12 0.0033
159 THERAPEUTIC RESPONSE UNEXPECTED 146 0.0033
160 SYNOVIAL CYST 15 0.0032
161 BLEPHARITIS 13 0.0032
162 STREPTOCOCCAL INFECTION 18 0.0032
163 EXTRA DOSE ADMINISTERED 130 0.0032
164 HAEMORRHAGIC ANAEMIA 14 0.0032
165 GENERALISED ERYTHEMA 18 0.0032
166 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 16 0.0032
167 SEPSIS 352 0.0032
168 THYROID MASS 12 0.0031
169 SKIN LACERATION 34 0.0031
170 CONJUNCTIVITIS 58 0.0031
171 EOSINOPHIL COUNT INCREASED 26 0.0031
172 PRODUCT DOSE OMISSION IN ERROR 88 0.0031
173 EYELID OEDEMA 36 0.0031
174 COUGH 867 0.0031
175 CONJUNCTIVAL HYPERAEMIA 11 0.0031
176 EYE DISCHARGE 32 0.0031
177 WEIGHT FLUCTUATION 32 0.0031
178 SHOULDER OPERATION 13 0.0030
179 POLYARTHRITIS 16 0.0030
180 NEPHROGENIC ANAEMIA 14 0.0030
181 POOR VENOUS ACCESS 31 0.0030
182 OROPHARYNGEAL DISCOMFORT 27 0.0030
183 INSOMNIA 796 0.0030
184 RESPIRATORY SYNCYTIAL VIRUS INFECTION 26 0.0030
185 EAR PAIN 58 0.0030
186 ILLNESS 307 0.0030
187 GINGIVITIS 16 0.0030
188 CANDIDA INFECTION 50 0.0030
189 ERYTHEMA OF EYELID 16 0.0030
190 SECRETION DISCHARGE 37 0.0030
191 DRY MOUTH 239 0.0029
192 VIRAL UPPER RESPIRATORY TRACT INFECTION 14 0.0029
193 MIDDLE INSOMNIA 55 0.0029
194 VIRAL INFECTION 98 0.0029
195 PURPURA 26 0.0029
196 VITAMIN D DECREASED 25 0.0029
197 SPINAL STENOSIS 12 0.0029
198 THYROID FUNCTION TEST ABNORMAL 12 0.0029
199 SKIN SWELLING 25 0.0029
200 HYPERSENSITIVITY 534 0.0029
201 HAEMOGLOBIN INCREASED 13 0.0028
202 SLEEP TERROR 12 0.0028
203 SENSITIVE SKIN 21 0.0028
204 BLOOD PRESSURE INCREASED 435 0.0028
205 PRODUCT PACKAGING ISSUE 27 0.0028
206 ORAL HERPES 55 0.0028
207 DERMATITIS EXFOLIATIVE 14 0.0028
208 NO ADVERSE EVENT 506 0.0028
209 ROSACEA 13 0.0028
210 EPISTAXIS 208 0.0028
211 SYNCOPE 278 0.0028
212 AUTOIMMUNE DISORDER 27 0.0028
213 RESPIRATION ABNORMAL 19 0.0028
214 OROPHARYNGEAL PAIN 254 0.0027
215 POOR QUALITY SLEEP 59 0.0027
216 COVID-19 480 0.0027
217 INITIAL INSOMNIA 28 0.0027
218 PNEUMONIA BACTERIAL 25 0.0027
219 SWELLING OF EYELID 17 0.0027
220 FOETAL DEATH 14 0.0027
221 CHOLECYSTITIS CHRONIC 18 0.0027
222 PSEUDOMONAS INFECTION 23 0.0027
223 ANAPHYLACTOID REACTION 11 0.0027
224 SENSITIVITY TO WEATHER CHANGE 14 0.0027
225 PEMPHIGOID 20 0.0026
226 FOOT DEFORMITY 29 0.0026
227 INJECTION SITE INFLAMMATION 13 0.0026
228 NERVE COMPRESSION 24 0.0026
229 HYPERVENTILATION 15 0.0026
230 PETECHIAE 27 0.0026
231 CONCUSSION 20 0.0026
232 MIGRAINE 246 0.0026
233 PRODUCTIVE COUGH 123 0.0026
234 SLEEP DISORDER 181 0.0026
235 VITAMIN D DEFICIENCY 25 0.0026
236 DYSLIPIDAEMIA 13 0.0026
237 PAPULE 18 0.0026
238 FEELING ABNORMAL 607 0.0025
239 CYSTIC FIBROSIS 14 0.0025
240 PLEURISY 15 0.0025
241 THIRST 45 0.0025
242 HYPERLIPIDAEMIA 30 0.0025
243 VISION BLURRED 343 0.0025
244 PRURITUS GENERALISED 54 0.0025
245 SENSATION OF FOREIGN BODY 21 0.0025
246 ROTATOR CUFF SYNDROME 32 0.0025
247 ANAPHYLACTIC SHOCK 64 0.0025
248 FOOT FRACTURE 47 0.0025
249 INJECTION SITE VESICLES 15 0.0025
250 ADRENAL INSUFFICIENCY 30 0.0025
251 HIATUS HERNIA 32 0.0025
252 EXPOSURE VIA SKIN CONTACT 64 0.0025
253 MUSCLE TIGHTNESS 40 0.0025
254 FIBROMYALGIA 60 0.0025
255 ANGIOEDEMA 109 0.0025
256 GASTROINTESTINAL INFECTION 22 0.0025
257 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 174 0.0024
258 SKIN EXFOLIATION 205 0.0024
259 ARTHROPOD BITE 18 0.0024
260 WHEEZING 144 0.0024
261 FEELING DRUNK 18 0.0024
262 CHOLANGITIS 15 0.0024
263 SKIN WARM 14 0.0024
264 MYALGIA 409 0.0024
265 BACK DISORDER 39 0.0024
266 LIMB INJURY 65 0.0024
267 RENAL CYST 19 0.0024
268 DRUG INEFFECTIVE 3142 0.0024
269 TOXIC SKIN ERUPTION 24 0.0024
270 DRY SKIN 318 0.0024
271 PRESCRIBED OVERDOSE 46 0.0024
272 CHOKING SENSATION 13 0.0024
273 HEPATITIS CHOLESTATIC 14 0.0023
274 BENIGN PROSTATIC HYPERPLASIA 12 0.0023
275 MUSCLE STRAIN 20 0.0023
276 TENDERNESS 24 0.0023
277 AFFECTIVE DISORDER 18 0.0023
278 IMPAIRED DRIVING ABILITY 26 0.0023
279 FATIGUE 1780 0.0023
280 HEADACHE 1426 0.0023
281 INTERVERTEBRAL DISC DEGENERATION 21 0.0023
282 DRUG-INDUCED LIVER INJURY 71 0.0023
283 HAND FRACTURE 16 0.0023
284 RESTLESS LEGS SYNDROME 41 0.0023
285 PAROSMIA 17 0.0023
286 SKIN PLAQUE 19 0.0023
287 RHEUMATOID FACTOR POSITIVE 13 0.0022
288 SWELLING FACE 146 0.0022
289 COMPRESSION FRACTURE 12 0.0022
290 KNEE OPERATION 22 0.0022
291 BRONCHIECTASIS 15 0.0022
292 PRODUCT RESIDUE PRESENT 12 0.0022
293 PARAESTHESIA ORAL 32 0.0022
294 EYE INFECTION 25 0.0022
295 OCULAR HYPERAEMIA 105 0.0022
296 INTENTIONAL DOSE OMISSION 63 0.0022
297 ABDOMINAL PAIN UPPER 453 0.0022
298 MATERNAL EXPOSURE BEFORE PREGNANCY 15 0.0022
299 HYSTERECTOMY 19 0.0022
300 LIP SWELLING 73 0.0022
301 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 17 0.0022
302 NONSPECIFIC REACTION 12 0.0022
303 PELVIC FRACTURE 17 0.0022
304 EYE SWELLING 81 0.0022
305 TYPE 1 DIABETES MELLITUS 13 0.0022
306 TENDON DISORDER 14 0.0021
307 LYMPHADENOPATHY 76 0.0021
308 PRODUCT TASTE ABNORMAL 29 0.0021
309 SKIN INFECTION 24 0.0021
310 PULMONARY ALVEOLAR HAEMORRHAGE 12 0.0021
311 PYREXIA 739 0.0021
312 ORAL CANDIDIASIS 28 0.0021
313 DYSPHONIA 124 0.0021
314 TASTE DISORDER 43 0.0021
315 NECK PAIN 118 0.0021
316 FRUSTRATION TOLERANCE DECREASED 17 0.0021
317 DERMATITIS 44 0.0021
318 IRRITABLE BOWEL SYNDROME 45 0.0021
319 INTENTIONAL PRODUCT USE ISSUE 182 0.0021
320 DERMATITIS BULLOUS 15 0.0021
321 WRONG PRODUCT ADMINISTERED 14 0.0021
322 HYPERCHOLESTEROLAEMIA 20 0.0021
323 SCIATICA 33 0.0021
324 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 14 0.0021
325 NEURALGIA 50 0.0021
326 IMPAIRED GASTRIC EMPTYING 28 0.0021
327 PRODUCT DISTRIBUTION ISSUE 19 0.0020
328 ORAL DISORDER 15 0.0020
329 PRODUCT USE IN UNAPPROVED INDICATION 507 0.0020
330 EYE MOVEMENT DISORDER 14 0.0020
331 ANAL ABSCESS 11 0.0020
332 SCREAMING 13 0.0020
333 GASTROOESOPHAGEAL REFLUX DISEASE 164 0.0020
334 DYSPNOEA 1152 0.0020
335 CHEILITIS 11 0.0020
336 COVID-19 PNEUMONIA 24 0.0020
337 PRODUCT USE COMPLAINT 32 0.0020
338 CHEST DISCOMFORT 208 0.0020
339 BLOOD IRON DECREASED 24 0.0020
340 ABDOMINAL PAIN 469 0.0020
341 INTERVERTEBRAL DISC PROTRUSION 44 0.0020
342 RASH ERYTHEMATOUS 96 0.0020
343 EXTRASYSTOLES 14 0.0020
344 CARPAL TUNNEL SYNDROME 28 0.0020
345 ARTHRALGIA 831 0.0020
346 BLOOD POTASSIUM DECREASED 60 0.0020
347 RASH PRURITIC 108 0.0020
348 SEDATION 52 0.0020
349 PRODUCT PREPARATION ISSUE 13 0.0020
350 DECREASED APPETITE 459 0.0020
351 WALKING AID USER 13 0.0020
352 UNEVALUABLE EVENT 149 0.0020
353 SWELLING 184 0.0020
354 PYELONEPHRITIS 17 0.0020
355 PRODUCT DOSE OMISSION ISSUE 576 0.0020
356 BOWEL MOVEMENT IRREGULARITY 15 0.0020
357 INJECTION SITE URTICARIA 48 0.0020
358 DECREASED ACTIVITY 21 0.0019
359 INFUSION RELATED REACTION 129 0.0019
360 FALL 645 0.0019
361 DIZZINESS 966 0.0019
362 BACK INJURY 21 0.0019
363 DYSURIA 71 0.0019
364 INFLUENZA 215 0.0019
365 CHOLECYSTECTOMY 22 0.0019
366 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 347 0.0019
367 SWOLLEN TONGUE 60 0.0019
368 INTERSTITIAL LUNG DISEASE 93 0.0019
369 RASH 833 0.0019
370 BLOOD SODIUM DECREASED 36 0.0019
371 TOOTH FRACTURE 21 0.0019
372 FACIAL PAIN 17 0.0019
373 SPUTUM DISCOLOURED 18 0.0019
374 NOCTURIA 23 0.0019
375 SURGERY 111 0.0019
376 BRONCHOSPASM 27 0.0019
377 CONTUSION 182 0.0019
378 INJECTION SITE RASH 58 0.0019
379 FUNGAL INFECTION 63 0.0019
380 LOW BIRTH WEIGHT BABY 15 0.0019
381 PHARYNGEAL OEDEMA 29 0.0019
382 DISCOMFORT 115 0.0019
383 FOREIGN BODY SENSATION IN EYES 12 0.0019
384 PALPITATIONS 220 0.0019
385 HAIR GROWTH ABNORMAL 13 0.0019
386 RETCHING 40 0.0019
387 RESPIRATORY DISORDER 56 0.0019
388 SCAR 32 0.0019
389 TOOTH ABSCESS 19 0.0019
390 CELLULITIS 94 0.0019
391 HERPES ZOSTER 107 0.0019
392 EXOSTOSIS 17 0.0019
393 INFLAMMATION 96 0.0019
394 CARDIAC FLUTTER 12 0.0019
395 THROAT TIGHTNESS 50 0.0018
396 OSTEOPENIA 28 0.0018
397 TEMPERATURE INTOLERANCE 19 0.0018
398 SYSTEMIC LUPUS ERYTHEMATOSUS 65 0.0018
399 HEART RATE INCREASED 181 0.0018
400 TOOTH INFECTION 24 0.0018
401 DIARRHOEA HAEMORRHAGIC 17 0.0018
402 BLADDER DISORDER 18 0.0018
403 FOLLICULITIS 19 0.0018
404 LIMB DISCOMFORT 56 0.0018
405 THERAPEUTIC PRODUCT EFFECT DECREASED 81 0.0018
406 NASOPHARYNGITIS 333 0.0018
407 ABORTION INDUCED 17 0.0018
408 APHTHOUS ULCER 14 0.0018
409 VASCULITIS 21 0.0018
410 RASH MACULAR 63 0.0018
411 ORAL DISCOMFORT 25 0.0018
412 PULMONARY ARTERIAL HYPERTENSION 26 0.0018
413 URINARY TRACT INFECTION 306 0.0018
414 STAPHYLOCOCCAL INFECTION 59 0.0018
415 INJECTION SITE SWELLING 137 0.0018
416 BREAST MASS 12 0.0018
417 C-REACTIVE PROTEIN INCREASED 65 0.0018
418 GOUT 32 0.0018
419 INCREASED APPETITE 34 0.0018
420 HEAVY MENSTRUAL BLEEDING 16 0.0018
421 TOXIC EPIDERMAL NECROLYSIS 27 0.0018
422 SUPRAVENTRICULAR TACHYCARDIA 17 0.0018
423 URINARY RETENTION 59 0.0018
424 CHOLECYSTITIS 21 0.0018
425 LIP DRY 16 0.0018
426 HYPOPHOSPHATAEMIA 13 0.0018
427 CEREBRAL DISORDER 13 0.0018
428 PHOTOSENSITIVITY REACTION 29 0.0018
429 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 30 0.0017
430 BIPOLAR DISORDER 19 0.0017
431 ONYCHOCLASIS 12 0.0017
432 MUSCULOSKELETAL DISCOMFORT 30 0.0017
433 LOSS OF CONSCIOUSNESS 223 0.0017
434 HOT FLUSH 131 0.0017
435 KIDNEY INFECTION 34 0.0017
436 HEPATOMEGALY 17 0.0017
437 ANOSMIA 25 0.0017
438 AUTOIMMUNE HEPATITIS 12 0.0017
439 HYPOAESTHESIA ORAL 26 0.0017
440 DISTURBANCE IN ATTENTION 93 0.0017
441 PRODUCT USE ISSUE 324 0.0017
442 HEPATIC STEATOSIS 32 0.0017
443 DENTAL CARIES 19 0.0017
444 URINE OUTPUT DECREASED 15 0.0017
445 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 82 0.0017
446 VERTIGO 104 0.0017
447 SPINAL OPERATION 21 0.0017
448 DISEASE RECURRENCE 81 0.0017
449 EYE IRRITATION 98 0.0017
450 RIB FRACTURE 35 0.0017
451 DYSPNOEA EXERTIONAL 64 0.0017
452 THYROID DISORDER 26 0.0017
453 DIARRHOEA 1087 0.0017
454 REBOUND EFFECT 19 0.0017
455 MALAISE 737 0.0017
456 ANKLE FRACTURE 26 0.0017
457 FEELING JITTERY 32 0.0017
458 OEDEMA 91 0.0017
459 OSTEOPOROSIS 69 0.0017
460 EYE INFLAMMATION 16 0.0017
461 NIGHT SWEATS 54 0.0017
462 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 12 0.0017
463 HEAD INJURY 53 0.0017
464 GASTRITIS 44 0.0017
465 WRIST FRACTURE 20 0.0017
466 ANAL INCONTINENCE 15 0.0017
467 ERYTHEMA 342 0.0017
468 PAIN IN JAW 47 0.0017
469 HALLUCINATION 125 0.0017
470 TONGUE DISORDER 12 0.0017
471 TOOTHACHE 30 0.0017
472 ATELECTASIS 16 0.0017
473 POLLAKIURIA 69 0.0017
474 LUPUS-LIKE SYNDROME 15 0.0017
475 ARTHRITIS 130 0.0017
476 HAEMOPTYSIS 46 0.0016
477 APHONIA 23 0.0016
478 RASH PUSTULAR 12 0.0016
479 HAIR TEXTURE ABNORMAL 22 0.0016
480 INFECTION 237 0.0016
481 NEPHROLITHIASIS 75 0.0016
482 FLUID RETENTION 83 0.0016
483 IRRITABILITY 98 0.0016
484 HYPOTHYROIDISM 52 0.0016
485 OSTEOARTHRITIS 69 0.0016
486 FEEDING DISORDER 33 0.0016
487 BLOOD MAGNESIUM DECREASED 14 0.0016
488 MUSCULOSKELETAL CHEST PAIN 25 0.0016
489 KNEE ARTHROPLASTY 34 0.0016
490 EYE DISORDER 53 0.0016
491 CYST 20 0.0016
492 BLOOD PRESSURE ABNORMAL 32 0.0016
493 CONSTIPATION 351 0.0016
494 SUNBURN 12 0.0016
495 BACTERIAL INFECTION 30 0.0016
496 HEPATIC ENCEPHALOPATHY 15 0.0016
497 MUSCLE DISORDER 13 0.0016
498 CYSTITIS 51 0.0016
499 CATARACT 95 0.0016
500 CHRONIC KIDNEY DISEASE 121 0.0016
501 BODY HEIGHT DECREASED 17 0.0016
502 FLATULENCE 90 0.0016
503 LUNG INFILTRATION 14 0.0016
504 HEPATIC FUNCTION ABNORMAL 59 0.0016
505 CONDITION AGGRAVATED 480 0.0016
506 GASTROENTERITIS 23 0.0016
507 RED BLOOD CELL COUNT DECREASED 45 0.0016
508 DRUG EFFECT INCOMPLETE 57 0.0016
509 OBESITY 25 0.0016
510 GALLBLADDER DISORDER 28 0.0016
511 BURSITIS 19 0.0016
512 BLOOD PRESSURE DECREASED 104 0.0016
513 SKIN DISORDER 52 0.0016
514 DRUG EXPOSURE DURING PREGNANCY 53 0.0016
515 CONTRAINDICATED PRODUCT ADMINISTERED 47 0.0016
516 ERUCTATION 30 0.0015
517 NEUTROPHIL COUNT DECREASED 63 0.0015
518 GASTROINTESTINAL PAIN 17 0.0015
519 PULMONARY MASS 23 0.0015
520 IMMUNODEFICIENCY 23 0.0015
521 ASTHENIA 580 0.0015
522 TENDON RUPTURE 19 0.0015
523 HAEMORRHOIDS 30 0.0015
524 MUSCLE SPASMS 282 0.0015
525 GAMMA-GLUTAMYLTRANSFERASE INCREASED 34 0.0015
526 ACCIDENTAL OVERDOSE 56 0.0015
527 ILEUS 19 0.0015
528 OEDEMA PERIPHERAL 186 0.0015
529 BURNING SENSATION 107 0.0015
530 THERAPY CHANGE 15 0.0015
531 IMMUNE SYSTEM DISORDER 20 0.0015
532 SARS-COV-2 TEST POSITIVE 20 0.0015
533 PNEUMONIA 490 0.0015
534 SKIN HYPERPIGMENTATION 13 0.0015
535 BLOOD CALCIUM DECREASED 17 0.0015
536 ANXIETY 430 0.0015
537 PANIC ATTACK 55 0.0015
538 HEART RATE IRREGULAR 34 0.0015
539 HYPOTONIA 15 0.0015
540 WITHDRAWAL SYNDROME 63 0.0015
541 JOINT INJURY 32 0.0015
542 BLINDNESS TRANSIENT 11 0.0015
543 SCAB 17 0.0015
544 PULMONARY HYPERTENSION 31 0.0015
545 NAUSEA 1177 0.0015
546 PERIPHERAL SWELLING 229 0.0015
547 ABDOMINAL DISTENSION 155 0.0015
548 END STAGE RENAL DISEASE 27 0.0015
549 POST PROCEDURAL INFECTION 12 0.0015
550 PLATELET COUNT DECREASED 157 0.0015
551 SKIN ULCER 38 0.0015
552 WEIGHT INCREASED 329 0.0015
553 PRODUCT PRESCRIBING ISSUE 32 0.0015
554 EUPHORIC MOOD 15 0.0015
555 HICCUPS 12 0.0015
556 LETHARGY 84 0.0015
557 PERIPHERAL COLDNESS 20 0.0015
558 HAIR DISORDER 12 0.0015
559 NODULE 19 0.0015
560 BACK PAIN 338 0.0015
561 DYSPEPSIA 143 0.0015
562 ANGER 49 0.0014
563 LIVER DISORDER 64 0.0014
564 ABDOMINAL DISCOMFORT 242 0.0014
565 GASTROINTESTINAL DISORDER 129 0.0014
566 RASH MACULO-PAPULAR 32 0.0014
567 VOMITING 676 0.0014
568 PRODUCT ODOUR ABNORMAL 15 0.0014
569 WOUND 40 0.0014
570 GLOSSODYNIA 32 0.0014
571 EOSINOPHILIA 25 0.0014
572 SKIN LESION 39 0.0014
573 DEPRESSION 323 0.0014
574 FEELING HOT 87 0.0014
575 DISABILITY 28 0.0014
576 JOINT STIFFNESS 37 0.0014
577 ROAD TRAFFIC ACCIDENT 59 0.0014
578 IRON DEFICIENCY ANAEMIA 13 0.0014
579 LOCALISED INFECTION 34 0.0014
580 LOWER LIMB FRACTURE 27 0.0014
581 IMPAIRED WORK ABILITY 30 0.0014
582 BLISTER 78 0.0014
583 OXYGEN SATURATION DECREASED 78 0.0014
584 BLOOD ALBUMIN DECREASED 11 0.0014
585 DEVICE DEFECTIVE 24 0.0014
586 PLATELET COUNT INCREASED 18 0.0014
587 INJECTION SITE PAIN 423 0.0014
588 INJECTION SITE ERYTHEMA 171 0.0014
589 BLOOD PRESSURE FLUCTUATION 33 0.0014
590 WHITE BLOOD CELL COUNT DECREASED 149 0.0014
591 EPILEPSY 42 0.0014
592 SPINAL DISORDER 13 0.0014
593 CHOLELITHIASIS 45 0.0014
594 DIVERTICULITIS 38 0.0014
595 WOUND INFECTION 15 0.0014
596 PARAESTHESIA 215 0.0014
597 TYPE 2 DIABETES MELLITUS 46 0.0014
598 HUNGER 19 0.0014
599 HYPOXIA 48 0.0014
600 EATING DISORDER 29 0.0014
601 INJECTION SITE DISCOLOURATION 17 0.0014
602 INTENTIONAL PRODUCT MISUSE 119 0.0014
603 TENDONITIS 21 0.0014
604 PREGNANCY 27 0.0013
605 LUNG DISORDER 66 0.0013
606 RESTLESSNESS 49 0.0013
607 MYOSITIS 12 0.0013
608 SUICIDAL IDEATION 122 0.0013
609 INJECTION SITE PRURITUS 89 0.0013
610 CLOSTRIDIUM DIFFICILE INFECTION 29 0.0013
611 DYSPHAGIA 126 0.0013
612 COELIAC DISEASE 13 0.0013
613 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 69 0.0013
614 PELVIC PAIN 24 0.0013
615 PNEUMONIA ASPIRATION 33 0.0013
616 MOOD ALTERED 36 0.0013
617 BLOOD UREA INCREASED 22 0.0013
618 DEHYDRATION 175 0.0013
619 ANAEMIA 250 0.0013
620 ARRHYTHMIA 62 0.0013
621 COMPLICATION ASSOCIATED WITH DEVICE 19 0.0013
622 BLOOD THYROID STIMULATING HORMONE INCREASED 12 0.0013
623 DEAFNESS 34 0.0013
624 SALIVARY HYPERSECRETION 13 0.0013
625 INCORRECT PRODUCT ADMINISTRATION DURATION 28 0.0013
626 FAECES DISCOLOURED 28 0.0013
627 AGRANULOCYTOSIS 24 0.0013
628 EMPHYSEMA 13 0.0013
629 BLOOD ALKALINE PHOSPHATASE INCREASED 32 0.0013
630 MEMORY IMPAIRMENT 177 0.0013
631 BLOOD CHOLESTEROL INCREASED 60 0.0013
632 RENAL IMPAIRMENT 108 0.0013
633 HEART RATE DECREASED 45 0.0013
634 PEMPHIGUS 16 0.0013
635 INJECTION SITE REACTION 88 0.0013
636 MUSCULOSKELETAL PAIN 67 0.0013
637 HYPOAESTHESIA 191 0.0013
638 MUSCULAR WEAKNESS 145 0.0013
639 STOMATITIS 77 0.0013
640 INJECTION SITE BRUISING 101 0.0013
641 PSYCHOMOTOR HYPERACTIVITY 21 0.0013
642 JAUNDICE 34 0.0013
643 PAIN 776 0.0013
644 STEVENS-JOHNSON SYNDROME 28 0.0013
645 NERVE INJURY 14 0.0013
646 CHEST PAIN 232 0.0013
647 WHITE BLOOD CELL COUNT INCREASED 48 0.0012
648 COLD SWEAT 22 0.0012
649 THERAPY INTERRUPTED 89 0.0012
650 HYPERTHYROIDISM 18 0.0012
651 SKIN DISCOLOURATION 57 0.0012
652 INFLUENZA LIKE ILLNESS 102 0.0012
653 CRYING 45 0.0012
654 INJECTION SITE DISCOMFORT 13 0.0012
655 PSORIATIC ARTHROPATHY 50 0.0012
656 CHOKING 24 0.0012
657 INCONTINENCE 13 0.0012
658 JOINT DISLOCATION 13 0.0012
659 MICTURITION URGENCY 14 0.0012
660 ADVERSE DRUG REACTION 110 0.0012
661 ASPARTATE AMINOTRANSFERASE INCREASED 65 0.0012
662 VITREOUS FLOATERS 12 0.0012
663 NEUROPATHY PERIPHERAL 116 0.0012
664 HOSPICE CARE 12 0.0012
665 MUSCLE TWITCHING 28 0.0012
666 TOOTH DISORDER 27 0.0012
667 PULMONARY CONGESTION 16 0.0012
668 COLITIS 46 0.0012
669 PALLOR 33 0.0012
670 ABNORMAL BEHAVIOUR 48 0.0012
671 DEPRESSED MOOD 64 0.0012
672 BLOOD TEST ABNORMAL 17 0.0012
673 ORAL PAIN 27 0.0012
674 RASH PAPULAR 27 0.0012
675 BALANCE DISORDER 104 0.0012
676 PRESCRIBED UNDERDOSE 24 0.0012
677 AGEUSIA 30 0.0012
678 NEEDLE ISSUE 35 0.0012
679 OVARIAN CYST 12 0.0012
680 POST PROCEDURAL COMPLICATION 23 0.0012
681 DRUG INTERACTION 190 0.0012
682 RASH GENERALISED 31 0.0012
683 ELECTROCARDIOGRAM QT PROLONGED 43 0.0012
684 FULL BLOOD COUNT DECREASED 24 0.0012
685 EXPOSURE DURING PREGNANCY 74 0.0012
686 FLUSHING 121 0.0012
687 OESOPHAGITIS 13 0.0012
688 PRODUCT PHYSICAL ISSUE 24 0.0012
689 PROCEDURAL PAIN 33 0.0012
690 BLOOD TRIGLYCERIDES INCREASED 21 0.0012
691 THERAPY CESSATION 61 0.0012
692 LIVER INJURY 29 0.0012
693 DELIRIUM 41 0.0012
694 INJECTION SITE NODULE 13 0.0012
695 THINKING ABNORMAL 22 0.0012
696 DRUG LEVEL DECREASED 12 0.0012
697 BODY TEMPERATURE INCREASED 24 0.0012
698 HIP ARTHROPLASTY 18 0.0012
699 ACCIDENT 14 0.0012
700 MUSCLE RIGIDITY 14 0.0012
701 HYPOKALAEMIA 54 0.0012
702 PRODUCT PREPARATION ERROR 24 0.0012
703 MALNUTRITION 13 0.0012
704 PARANOIA 20 0.0012
705 AGGRESSION 58 0.0012
706 HEPATIC ENZYME INCREASED 79 0.0012
707 UPPER LIMB FRACTURE 23 0.0012
708 BASAL CELL CARCINOMA 18 0.0012
709 MUSCULOSKELETAL STIFFNESS 101 0.0012
710 CHROMATURIA 26 0.0012
711 GAIT DISTURBANCE 220 0.0011
712 FEELING COLD 32 0.0011
713 PRODUCT DISPENSING ERROR 25 0.0011
714 PAIN IN EXTREMITY 337 0.0011
715 ACUTE RESPIRATORY FAILURE 22 0.0011
716 WEIGHT DECREASED 319 0.0011
717 HYPERHIDROSIS 147 0.0011
718 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
719 MOUTH ULCERATION 24 0.0011
720 SEIZURE 131 0.0011
721 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 229 0.0011
722 ELECTROLYTE IMBALANCE 13 0.0011
723 MENTAL IMPAIRMENT 27 0.0011
724 COGNITIVE DISORDER 52 0.0011
725 DERMATITIS ALLERGIC 14 0.0011
726 BLOOD BILIRUBIN INCREASED 30 0.0011
727 TREMOR 184 0.0011
728 ALANINE AMINOTRANSFERASE INCREASED 68 0.0011
729 ALOPECIA 217 0.0011
730 HYPOKINESIA 16 0.0011
731 PLEURAL EFFUSION 67 0.0011
732 RHEUMATOID ARTHRITIS 125 0.0011
733 PULMONARY THROMBOSIS 12 0.0011
734 ABORTION SPONTANEOUS 44 0.0011
735 HYPOPHAGIA 28 0.0011
736 BONE PAIN 64 0.0011
737 THERAPY NON-RESPONDER 49 0.0011
738 DISORIENTATION 43 0.0011
739 DYSKINESIA 44 0.0011
740 BLOOD CREATINE PHOSPHOKINASE INCREASED 31 0.0011
741 MASS 15 0.0011
742 HYPERTENSION 227 0.0011
743 HEPATIC CIRRHOSIS 20 0.0011
744 PULMONARY EMBOLISM 101 0.0011
745 SENSORY DISTURBANCE 17 0.0011
746 DEVICE DELIVERY SYSTEM ISSUE 29 0.0011
747 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 31 0.0011
748 CARDIOMEGALY 13 0.0011
749 ADVERSE REACTION 14 0.0011
750 ECONOMIC PROBLEM 16 0.0011
751 INJECTION SITE MASS 39 0.0011
752 SYNOVITIS 19 0.0011
753 INJURY 74 0.0011
754 SKIN IRRITATION 48 0.0010
755 HAIR COLOUR CHANGES 13 0.0010
756 TOOTH EXTRACTION 13 0.0010
757 DEVICE RELATED INFECTION 16 0.0010
758 PSORIASIS 135 0.0010
759 UNDERDOSE 75 0.0010
760 DYSSTASIA 30 0.0010
761 DYSGEUSIA 76 0.0010
762 SKIN CANCER 22 0.0010
763 INJECTION SITE IRRITATION 13 0.0010
764 MATERNAL EXPOSURE DURING PREGNANCY 91 0.0010
765 PANCYTOPENIA 57 0.0010
766 VISUAL IMPAIRMENT 126 0.0010
767 LABORATORY TEST ABNORMAL 30 0.0010
768 HEPATITIS 26 0.0010
769 TUBULOINTERSTITIAL NEPHRITIS 19 0.0010
770 HAEMATOCRIT DECREASED 20 0.0010
771 AGITATION 74 0.0010
772 ARTHROPATHY 56 0.0010
773 INJECTION SITE INDURATION 13 0.0010
774 MELAENA 22 0.0010
775 SPINAL FRACTURE 20 0.0010
776 LIVER FUNCTION TEST ABNORMAL 29 0.0010
777 HAND DEFORMITY 13 0.0010
778 CHOLESTASIS 19 0.0010
779 ANHEDONIA 26 0.0010
780 MOBILITY DECREASED 71 0.0010
781 GLAUCOMA 19 0.0010
782 ANKYLOSING SPONDYLITIS 13 0.0010
783 JOINT SWELLING 119 0.0010
784 BLOOD POTASSIUM INCREASED 16 0.0010
785 CEREBRAL INFARCTION 24 0.0010
786 LIVER FUNCTION TEST INCREASED 21 0.0010
787 MUSCLE SPASTICITY 12 0.0010
788 HYPERCALCAEMIA 12 0.0010
789 DIABETES MELLITUS 74 0.0010
790 JOINT RANGE OF MOTION DECREASED 13 0.0010
791 QUALITY OF LIFE DECREASED 13 0.0010
792 PAIN OF SKIN 26 0.0010
793 MENTAL DISORDER 42 0.0010
794 PULMONARY OEDEMA 43 0.0010
795 NERVOUSNESS 50 0.0010
796 ILL-DEFINED DISORDER 58 0.0010
797 CYANOSIS 15 0.0010
798 AMNESIA 62 0.0010
799 PRODUCT QUALITY ISSUE 129 0.0009
800 BLOOD URINE PRESENT 18 0.0009
801 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 52 0.0009
802 GASTRIC ULCER 18 0.0009
803 PNEUMOTHORAX 15 0.0009
804 URINARY INCONTINENCE 28 0.0009
805 RENAL DISORDER 44 0.0009
806 IMPAIRED HEALING 31 0.0009
807 ACCIDENTAL EXPOSURE TO PRODUCT 97 0.0009
808 INTRAOCULAR PRESSURE INCREASED 12 0.0009
809 PULMONARY FIBROSIS 18 0.0009
810 PRODUCT SUBSTITUTION ISSUE 54 0.0009
811 ATRIAL FIBRILLATION 90 0.0009
812 BEDRIDDEN 12 0.0009
813 THROMBOCYTOPENIA 102 0.0009
814 ACTIVITIES OF DAILY LIVING IMPAIRED 18 0.0009
815 VENTRICULAR TACHYCARDIA 15 0.0009
816 DEEP VEIN THROMBOSIS 59 0.0009
817 HYPOACUSIS 39 0.0009
818 RESPIRATORY DISTRESS 25 0.0009
819 LYMPHOCYTE COUNT DECREASED 16 0.0009
820 MOVEMENT DISORDER 29 0.0009
821 EXPIRED PRODUCT ADMINISTERED 30 0.0009
822 INCORRECT DOSE ADMINISTERED 206 0.0009
823 HIP FRACTURE 29 0.0009
824 LUNG INFECTION 14 0.0009
825 TRANSAMINASES INCREASED 20 0.0009
826 OFF LABEL USE 787 0.0009
827 FRACTURE 17 0.0009
828 THERAPY PARTIAL RESPONDER 14 0.0009
829 DEMENTIA 25 0.0009
830 MUSCULOSKELETAL DISORDER 17 0.0009
831 INTENTIONAL SELF-INJURY 18 0.0009
832 ACUTE KIDNEY INJURY 136 0.0009
833 DEPRESSED LEVEL OF CONSCIOUSNESS 35 0.0009
834 BLOOD LACTATE DEHYDROGENASE INCREASED 14 0.0009
835 MOOD SWINGS 28 0.0009
836 TREATMENT NONCOMPLIANCE 48 0.0009
837 DYSARTHRIA 33 0.0009
838 SEPTIC SHOCK 38 0.0009
839 BLOOD CREATININE INCREASED 57 0.0009
840 ANGINA PECTORIS 25 0.0009
841 BRAIN OEDEMA 11 0.0009
842 GAIT INABILITY 29 0.0009
843 TRANSIENT ISCHAEMIC ATTACK 29 0.0009
844 THROMBOSIS 69 0.0009
845 HAEMOGLOBIN DECREASED 88 0.0009
846 HALLUCINATION, VISUAL 18 0.0009
847 SKIN REACTION 12 0.0009
848 DRUG INTOLERANCE 82 0.0008
849 SINUS TACHYCARDIA 12 0.0008
850 CYTOMEGALOVIRUS INFECTION 14 0.0008
851 PRODUCT PRESCRIBING ERROR 20 0.0008
852 APHASIA 25 0.0008
853 PRODUCT DOSE OMISSION 54 0.0008
854 SHOCK 19 0.0008
855 INTESTINAL OBSTRUCTION 31 0.0008
856 GENERAL PHYSICAL HEALTH DETERIORATION 95 0.0008
857 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 21 0.0008
858 EMOTIONAL DISORDER 25 0.0008
859 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
860 HAEMATOCHEZIA 44 0.0008
861 CARDIAC FAILURE 64 0.0008
862 PANCREATITIS 42 0.0008
863 PRODUCT ADMINISTRATION ERROR 16 0.0008
864 PROTEINURIA 15 0.0008
865 DEVICE OCCLUSION 11 0.0008
866 INJECTION SITE WARMTH 16 0.0008
867 HERNIA 15 0.0008
868 CONFUSIONAL STATE 125 0.0008
869 DYSTONIA 15 0.0008
870 MULTIPLE SCLEROSIS RELAPSE 53 0.0008
871 BRADYCARDIA 41 0.0008
872 HAEMATOMA 20 0.0008
873 HYPOTENSION 154 0.0008
874 METRORRHAGIA 13 0.0008
875 CARDIAC DISORDER 71 0.0008
876 PANCREATITIS ACUTE 17 0.0008
877 HALLUCINATION, AUDITORY 12 0.0008
878 PRODUCT AVAILABILITY ISSUE 17 0.0007
879 RENAL FAILURE 99 0.0007
880 SPEECH DISORDER 39 0.0007
881 FEMUR FRACTURE 23 0.0007
882 SUICIDE ATTEMPT 45 0.0007
883 FEBRILE NEUTROPENIA 49 0.0007
884 COLON CANCER 11 0.0007
885 RHABDOMYOLYSIS 30 0.0007
886 LEUKOCYTOSIS 13 0.0007
887 GLYCOSYLATED HAEMOGLOBIN INCREASED 18 0.0007
888 MULTIPLE SCLEROSIS 34 0.0007
889 HOSPITALISATION 109 0.0007
890 FEAR 19 0.0007
891 NERVOUS SYSTEM DISORDER 22 0.0007
892 BLOOD GLUCOSE ABNORMAL 13 0.0007
893 PNEUMONITIS 19 0.0007
894 EMOTIONAL DISTRESS 84 0.0007
895 ENCEPHALOPATHY 17 0.0007
896 PERICARDIAL EFFUSION 16 0.0007
897 DEVICE DISLOCATION 30 0.0007
898 ORTHOSTATIC HYPOTENSION 12 0.0007
899 HYPOCALCAEMIA 13 0.0007
900 HYPERGLYCAEMIA 25 0.0007
901 DEVICE USE ISSUE 12 0.0007
902 AMENORRHOEA 12 0.0007
903 SKIN BURNING SENSATION 49 0.0007
904 LOWER RESPIRATORY TRACT INFECTION 31 0.0007
905 ACUTE MYOCARDIAL INFARCTION 20 0.0007
906 GASTRIC DISORDER 23 0.0007
907 OSTEONECROSIS 22 0.0007
908 DRUG EFFECT DECREASED 36 0.0007
909 BLOOD PRESSURE SYSTOLIC INCREASED 13 0.0007
910 OSTEOMYELITIS 12 0.0007
911 ADVERSE EVENT 61 0.0007
912 RENAL FAILURE ACUTE 28 0.0007
913 BONE DISORDER 12 0.0007
914 DEVICE ISSUE 58 0.0006
915 RESPIRATORY FAILURE 47 0.0006
916 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 15 0.0006
917 OVERDOSE 136 0.0006
918 TOOTH LOSS 13 0.0006
919 COLITIS ULCERATIVE 28 0.0006
920 GASTROINTESTINAL HAEMORRHAGE 52 0.0006
921 HAEMORRHAGE 65 0.0006
922 ACNE 47 0.0006
923 DEVICE MALFUNCTION 43 0.0006
924 VISUAL ACUITY REDUCED 20 0.0006
925 HEPATIC FAILURE 18 0.0006
926 DRUG DOSE OMISSION 98 0.0006
927 PRODUCT COMPLAINT 15 0.0006
928 BONE MARROW FAILURE 12 0.0006
929 ERECTILE DYSFUNCTION 15 0.0006
930 DIABETIC KETOACIDOSIS 14 0.0006
931 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 41 0.0006
932 INCORRECT DOSE ADMINISTERED BY DEVICE 15 0.0006
933 PLASMA CELL MYELOMA 22 0.0006
934 MENSTRUATION IRREGULAR 15 0.0006
935 FREQUENT BOWEL MOVEMENTS 15 0.0006
936 HYPONATRAEMIA 31 0.0005
937 CONVULSION 31 0.0005
938 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15 0.0005
939 INTERNATIONAL NORMALISED RATIO INCREASED 15 0.0005
940 CARDIAC FAILURE CONGESTIVE 42 0.0005
941 DEVICE USE ERROR 18 0.0005
942 ABDOMINAL PAIN LOWER 13 0.0005
943 RECTAL HAEMORRHAGE 22 0.0005
944 DEVICE LEAKAGE 22 0.0005
945 RENAL INJURY 15 0.0005
946 UNRESPONSIVE TO STIMULI 13 0.0005
947 APPLICATION SITE PAIN 11 0.0005
948 DISEASE PROGRESSION 59 0.0005
949 MALIGNANT NEOPLASM PROGRESSION 51 0.0005
950 TARDIVE DYSKINESIA 14 0.0005
951 DEVICE BREAKAGE 20 0.0005
952 BLOOD GLUCOSE INCREASED 92 0.0005
953 BREAST CANCER FEMALE 13 0.0005
954 ABASIA 12 0.0005
955 INTENTIONAL OVERDOSE 31 0.0005
956 BLOOD GLUCOSE DECREASED 23 0.0005
957 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 22 0.0005
958 TREATMENT FAILURE 39 0.0005
959 WRONG TECHNIQUE IN DRUG USAGE PROCESS 17 0.0005
960 CORONARY ARTERY DISEASE 14 0.0005
961 LUNG NEOPLASM MALIGNANT 19 0.0005
962 VAGINAL HAEMORRHAGE 20 0.0005
963 HYPERKALAEMIA 16 0.0005
964 DRUG ADMINISTRATION ERROR 14 0.0005
965 NEUTROPENIA 62 0.0005
966 HYPOGLYCAEMIA 22 0.0005
967 BONE DENSITY DECREASED 14 0.0004
968 MYELOSUPPRESSION 16 0.0004
969 LACTIC ACIDOSIS 14 0.0004
970 MENTAL STATUS CHANGES 12 0.0004
971 INJECTION SITE HAEMORRHAGE 34 0.0004
972 CEREBRAL HAEMORRHAGE 15 0.0004
973 MEDICATION ERROR 23 0.0004
974 LEUKOPENIA 20 0.0004
975 DRUG WITHDRAWAL SYNDROME 35 0.0004
976 CARDIAC ARREST 32 0.0004
977 BREAST CANCER 36 0.0004
978 CEREBROVASCULAR ACCIDENT 65 0.0004
979 FOETAL EXPOSURE DURING PREGNANCY 31 0.0004
980 DEVICE DIFFICULT TO USE 25 0.0004
981 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 12 0.0004
982 DRUG DOSE OMISSION BY DEVICE 27 0.0003
983 PRODUCT ADHESION ISSUE 12 0.0003
984 PRODUCT STORAGE ERROR 28 0.0003
985 MYOCARDIAL INFARCTION 55 0.0003
986 NEOPLASM MALIGNANT 20 0.0003
987 DEATH 208 0.0002
988 DRUG DEPENDENCE 35 0.0002
989 TOXICITY TO VARIOUS AGENTS 35 0.0002
990 DEVICE EXPULSION 13 0.0002
991 DRUG ABUSE 15 0.0002